APA (7th ed.) Citation

Hou, X., Liu, S., Liu, J., Zhou, J., Liang, Y., & Cui, L. (2023). The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer. Clinical biochemistry, 119, 110615. https://doi.org/10.1016/j.clinbiochem.2023.110615

Chicago Style (17th ed.) Citation

Hou, Xiuzhu, Shanshan Liu, Jing Liu, Jiansuo Zhou, Yongming Liang, and Liyan Cui. "The Performance of Carbohydrate Antigen 125-Thomsen-nouveau and Anti-Müllerian Hormone Combined with CA125, Human Epididymis Protein 4 and Risk of Malignancy Algorithm in Diagnosis for Patients with Epithelial Ovarian Cancer." Clinical Biochemistry 119 (2023): 110615. https://doi.org/10.1016/j.clinbiochem.2023.110615.

MLA (9th ed.) Citation

Hou, Xiuzhu, et al. "The Performance of Carbohydrate Antigen 125-Thomsen-nouveau and Anti-Müllerian Hormone Combined with CA125, Human Epididymis Protein 4 and Risk of Malignancy Algorithm in Diagnosis for Patients with Epithelial Ovarian Cancer." Clinical Biochemistry, vol. 119, 2023, p. 110615, https://doi.org/10.1016/j.clinbiochem.2023.110615.